Nature Structural & Molecular Biology Impact Factor

Among Biophysics journals, Nature Structural & Molecular Biology ranks in the top 5% by impact factor (JCR 2024). This ranking is based on our analysis of 20,449 journals in the Clarivate JCR 2024 database.

NSMB at 10.1 sits in the top tier of structural and biophysical journals, not because of raw citation volume, but because the journal's citation community is concentrated. Structural biologists, mechanistic biochemists, and molecular biologists all cite NSMB papers when they need the definitive structure-mechanism connection for a system. That audience specificity is why the five-year JIF (12.1) runs 20% above the two-year: structural insights compound as the field builds on them. A solved ribosome structure, a chaperone mechanism, or a splicing complex architecture becomes a standard citation for years after publication.

NSMB publishes around 250 papers per year at 28,276 total cites. That is a concentrated citation footprint: each paper is doing real citation work in the field, not just padding a high-volume journal's average.

Comparing NSMB's 10.1 to Cell (42.5) or Molecular Cell (16.6) is a field-specific citation rate question, not a quality question. Structural biology journals cite differently than broader molecular biology journals because the community is smaller and the papers tend to be referenced in the methods and introduction sections of primary research, not just in reviews. A structural biologist working on chromatin remodelers or bacterial toxin-antitoxin systems knows exactly what NSMB represents. The JIF understates the journal's actual authority in its domain.

In our pre-submission review work on manuscripts targeting Nature Structural & Molecular Biology, three patterns account for most of the desk rejections we see.

Structures solved without functional validation. NSMB's editorial position in the AlphaFold era is explicit: a cryo-EM or crystal structure alone is not sufficient. The journal wants structures that reveal mechanism, and mechanism requires functional testing. We see papers that present a high-resolution structure of a biologically important complex or machine, with the biological insight resting entirely on structural interpretation, "the interface suggests regulation by X" or "the active site architecture explains specificity for Y." Those interpretations need to be tested. Reviewers will ask for the mutagenesis experiments, the biochemical reconstitution, or the cellular assays that test the mechanistic hypothesis the structure generates. Papers submitted without that functional layer are desk-rejected or face revision requests for experiments that can take months.

Papers where the structure is technically impressive but the biological question is already answered. One of the more subtle patterns we see is papers solving the structure of a system where the structure is no longer the limiting factor for biological understanding. AlphaFold has changed which structures still have high information content. A structure that is experimentally determined but highly similar to the AlphaFold prediction, in the ground state, for a protein whose function is well established, faces an uphill editorial argument. NSMB reviewers will ask what the structure reveals that was not already available or predictable. Dynamic states, conformational changes during the functional cycle, complexes with regulatory partners, or structures that directly contradict the AlphaFold prediction are all answers to that question. A structure that confirms what was predicted is not.

Framing the paper as structural biology when the story is really molecular biology. NSMB publishes structural biology with mechanistic consequence, but it also publishes molecular biology papers where the key finding is mechanistic and the structural data is one component among several. We see authors who have a strong molecular biology paper with some structural data deciding to frame everything through a structural biology lens, because NSMB's name suggests it is the right target. Sometimes that works. More often, the structural component is not strong enough to be the protagonist, and the paper would be better targeted at Molecular Cell or EMBO Journal where the molecular biology can lead. The diagnostic question is whether the structure is the key that unlocks the mechanism, or whether it is one supporting data type among several in a molecular biology argument.

The decline from the 2021 peak follows the post-pandemic citation normalization seen across many journals. The current 10.1 is lower than the journal's recent historical range, which tracks a shift in structural biology citation patterns as the field's center of gravity moves with AI-based structure prediction.

For submission planning, 10.1 is the current operative number.

NSMB editors want structures that matter biologically. A technically impressive cryo-EM structure without biological insight will struggle. The journal rewards:

• Structures that explain a biological mechanism the field has been waiting to understand
• Structural work with functional validation that tests the mechanistic hypothesis
• Papers where the structural data answers an outstanding biological question
• Studies that combine structural biology with biochemistry, cell biology, or genetics
• Work where the structure reveals something unexpected about how a biological system works

What usually fails at editorial triage: structures solved primarily as technical demonstrations, incremental additions to known structural families without new biological insight, and papers where the functional validation is too thin to support the mechanistic claims.

Submit if:

• the structure reveals biological mechanism that the field has been waiting for
• the work combines structural data with functional validation
• the paper reads as biology informed by structure, not just structure
• the biological insight is novel enough to justify Nature Portfolio branding
• the structure provides mechanistic answers that cannot be obtained by other means

Think twice if:

• the structure is technically strong but biologically incremental
• Molecular Cell or a broader journal is a better match for the biological story
• the work is primarily methods or technique development rather than biological discovery
• the functional validation is incomplete
• a more specialized structural journal would reach the right audience

The cryo-EM revolution changed what is structurally achievable, and NSMB's editorial bar adjusted accordingly. Simply solving a new cryo-EM structure is no longer sufficient. The journal expects structures with biological context and functional testing.

AlphaFold and related AI tools have further shifted the landscape. Predicted structures are now available for most proteins, which means experimental structure determination needs to add something beyond prediction. NSMB papers increasingly need to show dynamics, complexes, or conformational states that prediction alone cannot capture.

• Whether the biological insight in your structure is novel enough
• How the functional validation will hold up under reviewer scrutiny
• Whether a broader journal would give the paper more visibility
• How long the editorial and review process will take
• Whether the structure prediction era has changed what editors are looking for in your specific subfield

NSMB's 10.1 is a structural-biology number, which means authors should resist reading it through the citation economics of broader molecular-biology journals. Structural journals rarely compete on the same raw citation scale as Cell or Molecular Cell. What matters is whether the structure becomes a durable mechanistic reference. The five-year JIF sitting above the two-year figure says that NSMB still publishes papers people return to when they need the structure-mechanism explanation, not just the first announcement.

That makes the submission decision narrower and more useful. NSMB is not the right venue because you solved a structure. It is the right venue when the structure answers the biological question in a way the field was actually waiting for. If the biological conclusion still feels mostly speculative after the structure is removed, the metric is describing the journal's reputation, not your paper's fit.

The trend is most useful when it keeps the editorial bar honest. In the AlphaFold and routine cryo-EM era, NSMB's influence comes from papers where experimental structure still changes what the field can confidently say about mechanism.